BASE PERIOD (YEAR 1): SUPPORT SERVICES RELATED TO CANCER REGISTRY CLAIMS ELECTRONIC DATA CAPTURE SOFTWARE SUPPORT AND INSTALLATIONS

法律要求所有50个州的医疗保健提供者向州癌症登记处报告新的癌症病例。美国国家癌症研究所（NCI）的监测，流行病学和最终结果（SEER）计划收集SEER覆盖地区的每一位癌症患者的数据。这些数据包括人口统计学、癌症描述、有限的初始治疗信息和患者随访，包括死亡患者的死亡原因。过去，登记数据的主要来源是医院。随着癌症护理和交付系统的日益复杂，越来越多的患者只能在医生的办公室接受治疗。因此，为了使SEER继续捕获所有癌症病例及其治疗信息，SEER有兴趣获得其他数据来源，例如来自肿瘤学实践的索赔数据。肿瘤学实践声明已被证明是详细的全身治疗信息的丰富来源，包括药物、剂量和给药日期等。 从2015年开始，NCI SEER计划开始支持从Unlimited Technology Systems，LLC采购六（6）个SEER中央癌症登记研究的肿瘤学实践声明数据。 无限技术系统有限责任公司提供医疗保健信息系统，以肿瘤学实践的国家社区。除了获得最近诊断病例的癌症治疗信息外，SEER还对评估纵向治疗以及进展和/或癌症复发的长期索赔历史感兴趣。要做到这一点，关键是要有一个很长的一系列纵向索赔同一癌症患者。SEER计划已经从肿瘤学实践和肿瘤学家（此处称为提供者）获得了格鲁吉亚、肯塔基州、路易斯安那州、新墨西哥州和犹他州2013-2017年以及爱荷华州2018年大量SEER癌症患者的索赔。目前Unlimited Technology Systems，LLC提供商已同意Unlimited Technology Systems，LLC向各自的中央癌症登记处发送索赔，以履行其报告癌症病例的义务。 SEER登记处目前正在使用这些索赔，以更快地确定新的癌症病例，因为索赔是每周收到的，以获取系统治疗和确定癌症患者生命状态方面的随访信息。SEER计划有兴趣继续支持当前提供商的索赔数据传输，并支持扩展此功能，以支持SEER区域内的其他提供商，或该计划确定为重要的癌症登记所覆盖的新州/地区，以获得索赔数据信息。该项目对于SEER继续具有相关性并推进癌症监测和研究至关重要。

Healthcare providers in all 50 states are required by law to report new cases of cancer to their state’s cancer registries. The National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) Program, collects data on each and every cancer patient in SEER covered areas. This data includes demographics, a description of their cancer, limited initial treatment information, and patient follow-up including cause of death for deceased patients. In the past the main source of registry data came from Hospitals. With the increasing complexity of cancer care and delivery systems, patients are being increasingly treated exclusively at physicians’ offices. Thus, for SEER to continue capturing all cancer cases and their treatment information SEER is interested in obtaining other sources of data such as claims data from oncology practices. Oncology practice claims has proven to be a rich source of information on detailed systemic therapy, including agents, doses administration dates etc. Beginning in 2015, the NCI SEER Program began supporting the procurement of oncology practice claims data for six (6) SEER central cancer registries from Unlimited Technology Systems, LLC. Unlimited Technology Systems, LLC provides healthcare information systems to a national community of oncology practices. In addition to obtaining cancer treatment information for cases recently diagnosed, SEER is interested in evaluating the long history of claims to assess longitudinal treatment as well as progression and/or cancer recurrence. To do this, it is crucial to have a very long series of longitudinal claims on the same cancer patient. The SEER Program has already obtained claims for a substantial number of SEER cancer patients for the years 2013-2017 for Georgia, Kentucky, Louisiana, New Mexico and Utah, and year 2018 for Iowa from oncology practices and oncologists, referenced here as providers. The current Unlimited Technology Systems, LLC providers have already provided consent to Unlimited Technology Systems, LLC to send claims to the respective central cancer registries to fulfil their obligation in reporting cancer cases. These claims are currently being used by SEER registries to ascertain new cancer cases more rapidly as the claims are received weekly, to capture systemic therapy and to ascertain follow-up information in terms of vital status of cancer patients. The SEER Program is interested in continuing to support the transmission of claims data for current providers, as well as to support the expansion of this capability, for additional providers within the SEER regions, or new states/areas covered by cancer registration that the Program identifies as important to obtain claims data information. This project is critical in order for SEER to continue being relevant and advance cancer surveillance and research.